JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Healthcare | 9.65% |
| 3 | Financials | 9.27% |
| 4 | Consumer Discretionary | 8.86% |
| 5 | Industrials | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5651
374Water
SCWO
$44.3M
| $66.9K | ﹤0.01% |
4,714
+875
| +23% | +$11.7K |
|
5652
X4 Pharmaceuticals
XFOR
$418M
| $66.9K | ﹤0.01% |
2,660
| – | – |
|
5653
First Trust Eurozone AlphaDEX
FEUZ
$134M
| $66.8K | ﹤0.01% |
1,644
| – | – |
|
5654
CALL
Century Aluminum
CENX
$4.62B
| $66.8K | ﹤0.01% |
+5,500
| New | +$43.2K |
|
5655
Oramed Pharmaceuticals
ORMP
$186M
| $66.4K | ﹤0.01% |
28,766
-17,250
| -37% | -$36.8K |
|
5656
iShares ESG Advanced High Yield Corporate Bond ETF
HYXF
$195M
| $66.3K | ﹤0.01% |
1,458
-623
| -30% | -$27.2K |
|
|
OPTN
5657
DELISTED
OptiNose
OPTN
| $66.2K | ﹤0.01% |
3,420
-1,353
| -28% | -$24.7K |
|
5658
SKYX Platforms
SKYX
$151M
| $66.1K | ﹤0.01% |
41,324
| – | – |
|
5659
GDS Holdings
GDS
$6.89B
| $66.1K | ﹤0.01% |
7,248
+345
| +5% | +$3.49K |
|
|
MYD
5660
DELISTED
BlackRock MuniYield Fund
MYD
| $66K | ﹤0.01% |
6,125
+5,821
| +1,915% | +$57.1K |
|
|
ASRT
5661
DELISTED
Assertio
ASRT
| $65.9K | ﹤0.01% |
4,104
| – | – |
|
5662
RPAR Risk Parity ETF
RPAR
$582M
| $65.8K | ﹤0.01% |
+3,442
| New | +$61.6K |
|
|
SWKH
5663
DELISTED
SWK Holdings
SWKH
| $65.5K | ﹤0.01% |
4,716
+1,635
| +53% | +$21.3K |
|
5664
First Trust Dow Jones Global Select Dividend Index Fund
FGD
$1.61B
| $65.2K | ﹤0.01% |
2,930
-1,482
| -34% | -$31.2K |
|
5665
Torrid Holdings
CURV
$219M
| $65K | ﹤0.01% |
11,262
+3,431
| +44% | +$11.7K |
|
5666
Invesco DB Oil Fund
DBO
$391M
| $64.9K | ﹤0.01% |
4,663
-11
| -0.2% | -$175 |
|
|
SILV
5667
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $64.6K | ﹤0.01% |
9,864
+9,087
| +1,169% | +$50.6K |
|
5668
Taysha Gene Therapies
TSHA
$1.9B
| $64.6K | ﹤0.01% |
36,484
+36,347
| +26,531% | +$72.5K |
|
5669
Valhi
VHI
$459M
| $64.6K | ﹤0.01% |
4,251
+2,006
| +89% | +$26.5K |
|
|
EEX
5670
DELISTED
Emerald Holding
EEX
| $63.9K | ﹤0.01% |
10,688
+568
| +6% | +$2.99K |
|
5671
Kodiak Sciences
KOD
$2.59B
| $63.9K | ﹤0.01% |
21,023
-3,286
| -14% | -$7.31K |
|
5672
NLI Holdings
NL
$315M
| $63.8K | ﹤0.01% |
11,370
+5,922
| +109% | +$29.7K |
|
|
PHK
5673
PIMCO High Income Fund
PHK
$858M
| $63.6K | ﹤0.01% |
+12,736
| New | +$57.8K |
|
5674
DNP Select Income Fund
DNP
$4.14B
| $63.5K | ﹤0.01% |
7,480
-16,596
| -69% | -$150K |
|
5675
Franklin International Low Volatility High Dividend Index ETF
LVHI
$5.59B
| $63.5K | ﹤0.01% |
2,294
+167
| +8% | +$4.58K |
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase deployed $33.3B of net new capital in Q4 2023, opening 701 new positions and adding to 3,666 existing holdings. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $3.18B trimmed.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 619 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.